RELATED CONTENT
June 7, 2024 — Shine Technologies, LLC, a pioneer in next-generation fusion-based technology, today announced a new ...
June 07, 2024 
News | Molecular Imaging
Janaury 10, 2022 — The Department of Energy’s National Nuclear Security Administration (NNSA) and Office of ...
January 10, 2022 
March 26, 2021 — Shine Medical Technologies LLC announced that construction of the exterior structure of its first-of-a ...
March 26, 2021 
News | Nuclear Imaging
December 18, 2020 — SHINE Medical Technologies LLC today announced that the company has broken ground on a new 54,000 ...
December 18, 2020 
Feature | Nuclear Imaging | By Willow Ascenzo
Medical imaging procedures such as single-photon emission computed tomography (SPECT) scans, myocardial perfusion scans ...
November 12, 2020 
October 28, 2019 — Phoenix LLC and Shine Medical Technologies LLC, nuclear technology companies focused on near-term ...
October 28, 2019 
News | Radiopharmaceuticals and Tracers | Jeff Zagoudis, Associate Editor
Shine Medical Technologies Inc. broke ground on their first medical isotope production facility in Janesville, Wis. U.S. Department of Energy (DOE) Under Secretary for Nuclear Security and Administrator of the National Nuclear Security Administration (NNSA) Lisa Gordon-Hagerty, Lantheus Medical Imaging President and CEO Mary Heino and Janesville City Manager Mark Freitag joined Shine founder and CEO, Greg Piefer, and the Shine team to celebrate the milestone.
May 10, 2019 March 1, 2016 — Wisconsin-based Shine Medical Technologies Inc., producer of medical tracers and cancer treatment ...
March 01, 2016 News
Lantheus Medical Imaging Inc. and Shine Medical Technologies Inc. announced that the companies have entered into a strategic agreement for the future supply of molybdenum-99 (Mo-99). The supply agreement marks Lantheus’ first with a prospective United States supplier of Mo-99.
November 07, 2014 